Bone Biologics Corporatio...

0.83
-0.06 (-6.61%)
At close: Mar 03, 2025, 3:59 PM
0.80
-3.94%
After-hours: Mar 03, 2025, 05:28 PM EST

Bone Biologics Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08
Cash & Equivalents 3.33M 3.03M 7.54M 6.68M n/a 24.14K 955.37K 690.28K 620.38K 1.12M 2.66M 1.54K 2.37 n/a n/a -39.77K n/a
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.00 n/a n/a n/a n/a n/a n/a
Receivables n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 75K n/a n/a n/a n/a n/a n/a
Inventory n/a n/a -579.91K n/a n/a n/a n/a n/a n/a n/a 983.86K n/a n/a n/a n/a n/a n/a
Other Current Assets 536.24K 711.19K 377.01K n/a n/a 6.68K 85.29K 105.23K 80.52K 425.93K 1.07M 85.77K n/a n/a n/a n/a n/a
Total Current Assets 3.86M 3.74M 8.5M 6.68M n/a 30.83K 1.04M 795.51K 972.84K 2.07M 3.81M 87.31K 2.37 n/a n/a -39.77K n/a
Property-Plant & Equipment n/a n/a n/a n/a n/a n/a 50.00 146.00 242.00 5.8K 11.62K n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets n/a n/a n/a n/a n/a n/a 50.00 146.00 242.00 5.8K 11.62K n/a n/a n/a n/a n/a n/a
Total Assets 3.86M 3.74M 8.5M 6.68M n/a 30.83K 1.04M 795.66K 973.09K 2.08M 3.82M 87.31K 2.37 n/a n/a -39.77K n/a
Account Payables n/a 360.66K 104.79K 99.91K 465.4K 42.88K 125.2K 216.9K 226.52K 186.81K 119.78K n/a n/a n/a n/a n/a n/a
Deferred Revenue n/a n/a 783.67K n/a n/a n/a n/a n/a 75.3K n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt n/a n/a n/a n/a 11.72M n/a 9M n/a 1.2M n/a 3.66M 4.13M n/a n/a n/a n/a n/a
Other Current Liabilities 377.71K 470.74K 2.44M n/a 1.5M 535.57K 513.68K 744.89K 75.3K 1.96M 95.61K 1.57M 4.68K n/a n/a n/a n/a
Total Current Liabilities 377.71K 831.4K 2.55M 99.91K 13.69M 578.45K 9.64M 961.79K 3.32M 2.15M 3.87M 5.7M 4.68K n/a n/a n/a n/a
Long-Term Debt n/a n/a n/a n/a n/a 11.32M n/a 8.23M 7.56M 5.08M 3.65M n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a n/a 888.46 n/a n/a 11.32M n/a 8.23M 6.28M 5.62M 3.65M n/a n/a n/a n/a n/a n/a
Total Liabilities 377.71K 831.4K 2.55M 99.91K 13.69M 11.9M 9.64M 9.19M 9.61M 7.76M 7.52M 5.7M 4.68K n/a n/a n/a n/a
Total Debt n/a n/a n/a n/a 11.72M 11.32M 9M 8.23M 7.48M 5.62M 7.3M 4.13M n/a n/a n/a n/a n/a
Common Stock 2.95K 534.00 15.3K 10.35K 30.68K 30.68K 26.45K 43.28K 38.83K 32.21K 24.27K 10.93K 10.93 n/a n/a n/a n/a
Retained Earnings -85.02M -80.91M -71.96M -70.48M -68.86M -67.04M -63.62M -59.19M -46.94M -25.91M -12.04M -7.61M -6.53K n/a n/a n/a n/a
Comprehensive Income n/a n/a n/a n/a n/a n/a n/a -357 -261 -3.98K -280 n/a n/a n/a n/a n/a n/a
Shareholders Equity 3.48M 2.91M 5.95M 6.58M -13.69M -11.87M -8.6M -8.4M -8.63M -5.68M -3.7M -5.61M -4.68K n/a n/a n/a n/a
Total Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a